Literature DB >> 21511256

miR-146a is modulated in human endothelial cell with aging.

Mariuca Vasa-Nicotera1, Hailan Chen, Paola Tucci, Ai Li Yang, Gaelle Saintigny, Rossella Menghini, Christian Mahè, Massimiliano Agostini, Richard A Knight, Gerry Melino, Massimo Federici.   

Abstract

BACKGROUND: Increasing evidence has demonstrated that the senescence of vascular endothelial cells has critical roles in the pathogenesis of vascular dysfunction such as atherosclerosis and thrombosis. MicroRNA (miR) are small non-coding RNAs that inhibit gene expression by binding to complementary sequences in the 3'UTR of their target mRNAs. MiRs modulate a variety of biological functions such as cell development, cell differentiation, and apoptosis. Moreover, several miRs involved in endothelial cell function have been identified. METHODS AND
RESULTS: Through a microarray approach, we have identified a miR-146a that is progressively modulated in endothelial cells with aging. In young human umbilical vein endothelial cells, this miR is involved in a premature senescence-like phenotype through direct targeting of the NOX4 protein, implicated in cell senescence and aging. CONCLUSIONS AND GENERAL SIGNIFICANCE: Finding important factors that regulate endothelial cell senescence, like miR-146a, will help provide novel therapeutic strategies for vascular disorders.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511256     DOI: 10.1016/j.atherosclerosis.2011.03.034

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  78 in total

Review 1.  The Nox family of NADPH oxidases: friend or foe of the vascular system?

Authors:  Ina Takac; Katrin Schröder; Ralf P Brandes
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 3.  Role of microRNAs in the trabecular meshwork.

Authors:  Pedro Gonzalez; Guorng Li; Jianming Qiu; Jing Wu; Coralia Luna
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-02       Impact factor: 2.671

4.  Aging and Protein Kinases.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead.

Authors:  Nathan Belkin; Scott M Damrauer
Journal:  Curr Cardiol Rep       Date:  2017-11-01       Impact factor: 2.931

Review 6.  MicroRNAs in endothelial cell homeostasis and vascular disease.

Authors:  Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

7.  IGF-1 deficiency in a critical period early in life influences the vascular aging phenotype in mice by altering miRNA-mediated post-transcriptional gene regulation: implications for the developmental origins of health and disease hypothesis.

Authors:  Stefano Tarantini; Cory B Giles; Jonathan D Wren; Nicole M Ashpole; M Noa Valcarcel-Ares; Jeanne Y Wei; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-08-26

8.  Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.

Authors:  Elisa Araldi; Aranzazu Chamorro-Jorganes; Coe van Solingen; C Fernández-Hernando; Y Suárez
Journal:  Curr Vasc Pharmacol       Date:  2013-05-13       Impact factor: 2.719

Review 9.  Regulation of SIRT1 by oxidative stress-responsive miRNAs and a systematic approach to identify its role in the endothelium.

Authors:  Zhen Chen; Tzu-Pin Shentu; Liang Wen; David A Johnson; John Y-J Shyy
Journal:  Antioxid Redox Signal       Date:  2013-04-25       Impact factor: 8.401

Review 10.  MicroRNAs: potential mediators and biomarkers of diabetic complications.

Authors:  Mitsuo Kato; Nancy E Castro; Rama Natarajan
Journal:  Free Radic Biol Med       Date:  2013-06-12       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.